Recently the New York Times ran a column about CFS patients in San Francisco getting free HIV drugs possibly at the expense of HIV patients competing for the same pool of free drugs from the manufacturer. However, the column didn't have any firm numbers regarding CFS patients so there was no way to tell if it was a trend or an isolated example. At Cure Talk we wondered. So we are asking you the patients. The results of this poll will be reported on Cure Talk, but respondents to the poll will remain anonymous.